The global peripheral artery disease market size reached USD 4.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.7 Billion by 2033, exhibiting a growth rate (CAGR) of 4.98% during 2025-2033. The rising number of geriatric populations, various technological innovations in the diagnosis and treatment, increasing adoption of home care settings, improvement in healthcare infrastructure, and changing living standards of individuals are propelling the market growth.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 4.9 Billion |
Market Forecast in 2033
|
USD 7.7 Billion |
Market Growth Rate (2025-2033) | 4.98% |
Peripheral artery disease (PAD) is a cardiovascular disorder wherein constricted arteries restrict blood flow to the limbs. It results in hair loss, leg numbness, feet or toe sores, painful cramps in hips and thighs, coldness and weak pulse in legs, and erectile dysfunction among men. It is caused when a plaque, also known as atherosclerosis, develops in leg arteries that carry oxygen and nutrient-rich blood from the heart to the arms and legs. It is diagnosed using the ankle-brachial index, ultrasound scan, angiography, blood tests, doppler and ultrasound (duplex) imaging, computed tomographic angiography (CT), and magnetic resonance angiography (MRA).
Changing Living Standards of Individuals
People are increasingly suffering from peripheral artery disease (PAD) due to lifestyle-related factors, such as diabetes, obesity, hypertension, and smoking. As global rates of these conditions increase, particularly in regions with aging populations, more individuals are at risk of PAD. Diabetes contributes to atherosclerosis, which narrows arteries and restricts blood flow, leading to PAD. As a result, the demand for diagnostic tools and treatments, such as angioplasty, stenting, and bypass surgery, is rising. Additionally, the global burden of cardiovascular diseases (CVDs) is pushing healthcare systems to focus on early detection and management of PAD.
Aging Population
The global aging population across the globe is contributing to peripheral artery disease market growth. Older adults face a higher risk of developing PAD owing to age-related vascular changes and atherosclerosis. As people age, their arteries naturally lose elasticity, which can result in narrowed or blocked arteries, a hallmark of PAD. This demographic shift drives demand for healthcare services including diagnostics, preventive treatments, and minimally invasive (MI) interventions like angioplasty and stent placement. In line with this, healthcare providers are increasingly focusing on addressing the needs of elderly patients, who often have complex health profiles, which is thereby increasing the peripheral artery disease market share.
Technological Advancements
Technological innovations in the diagnosis and treatment of peripheral artery disease (PAD) are significantly driving market growth. MI techniques such as endovascular therapies are revolutionizing PAD treatment by reducing recovery times and improving patient outcomes. Devices like drug-coated balloons, atherectomy systems, and advanced stents benefit in improving patient outcome without the need for open surgery. These technologies not only improve the efficacy of treatment but also make it accessible to a broader range of patients, including those who might not tolerate invasive procedures, thereby increasing peripheral artery disease market share. Additionally, improvements in diagnostic imaging are allowing for more accurate and earlier detection of PAD, which is critical in preventing complications such as limb amputation.
IMARC Group provides an analysis of the key trends in each sub-segment of the global peripheral artery disease market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on type and end user.
Breakup by Type:
Breakup by End User:
Breakup by Region:
The peripheral artery disease market research report has also provided a comprehensive analysis of the competitive landscape in the global market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Type, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Koninklijke Philips N.V., Medtronic plc and Terumo Corporation. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global peripheral artery disease market was valued at USD 4.9 Billion in 2024.
We expect the global peripheral artery disease market to exhibit a CAGR of 4.98% during 2025-2033.
The rising prevalence of cardiac diseases, along with the growing adoption of Minimally Invasive Surgeries (MIS), as they offer less postoperative pain, shortened hospital stay, faster recovery times, etc., is primarily driving the global peripheral artery disease market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective peripheral artery disease surgical procedures to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment or healthcare professionals.
Based on the type, the global peripheral artery disease market can be segmented into peripheral angioplasty balloons, peripheral stents, peripheral catheters, Inferior Vena Cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. Currently, peripheral stents hold the majority of the global market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global peripheral artery disease market include Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Koninklijke Philips N.V., Medtronic plc, and Terumo Corporation.